Literature DB >> 10336810

The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas.

H Koga1, Y Moriya, T Akasu, S Fujita.   

Abstract

AIMS: CEA-doubling time (CEA-dt) was calculated by measuring serum CEA at two voluntary points. As CEA-dt is correlated with tumour doubling time the growth rate of liver metastasis could be determined. We investigated the relationship between CEA-dt and prognosis to determine the indications for resection of liver metastasis.
METHODS: We examined 334 patients diagnosed with resected liver metastasis of colorectal carcinoma. Patients were divided into three categories based on CEA-dt; Group A, CEA-dt <30 days; Group B, 30 days </=cCEA-dt <80 days; and Group C, CEA-dt >/=s80 days. Clinicopathological parameters, the 3-year or 5-year survival rate and the rate of recurrence were compared among the three groups.
RESULTS: In Group A, the survival time after hepatic resection was significantly shorter compared to the other groups. Furthermore, multiple liver metastasis showed slightly reduced CEA-dt levels compared with solitary metastasis, but even in patients with solitary liver metastasis, the rate of survival was poor. In 70% of Group A patients, recurrent tumour was recognized within 1 year of hepatic resection.
CONCLUSION: When surgery for liver metastasis of colorectal cancer is considered. Group A patients should be recognized as having a poor prognosis and a high rate of recurrence after hepatic resection, and CEA-dt should be employed as a prognostic factor. Copyright 1999 W.B. Saunders Company Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336810     DOI: 10.1053/ejso.1998.0644

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.

Authors:  Hiroaki Miyake; Koji Murono; Hiroshi Nagata; Hiroaki Nozawa; Kazushige Kawai; Keisuke Hata; Toshiaki Tanaka; Takeshi Nishikawa; Yasutaka Shuno; Kazuhito Sasaki; Soichiro Ishihara
Journal:  Int J Colorectal Dis       Date:  2019-02-09       Impact factor: 2.571

2.  Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Yoshirou Fujii; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  Langenbecks Arch Surg       Date:  2004-07-03       Impact factor: 3.445

3.  Comparative lesion sequencing provides insights into tumor evolution.

Authors:  Siân Jones; Wei-Dong Chen; Giovanni Parmigiani; Frank Diehl; Niko Beerenwinkel; Tibor Antal; Arne Traulsen; Martin A Nowak; Christopher Siegel; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Joseph Willis; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

4.  Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Masaru Miura; Yoshiro Fujii; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

Review 5.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

6.  Risk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasis.

Authors:  Sung Won Jung; Dong-Sik Kim; Young Dong Yu; Jae Hyun Han; Sung-Ock Suh
Journal:  Ann Surg Treat Res       Date:  2016-05-02       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.